普萘洛尔选择性抑制再激活尼古丁相关记忆对尼古丁渴求的影响
该转化研究在大鼠和96名男性吸烟者中测试了非条件刺激(尼古丁)诱导的记忆提取-再巩固干预。大鼠中普萘洛尔注射抑制了尼古丁条件位置偏爱和操作式寻求,吸烟者中口服普萘洛尔降低了新学与既有尼古丁相关条件刺激及尼古丁启动诱导的偏好和渴求。
要点
- 尼古丁非条件刺激提取记忆后立即给予普萘洛尔可削弱大鼠尼古丁复吸行为。
- 吸烟者中尼古丁提取前口服普萘洛尔降低条件刺激及尼古丁启动诱导的偏好和渴求。
- 该记忆再巩固干预策略需进一步临床试验验证。
核心结论
- 非条件刺激诱导的记忆提取-再巩固干扰程序可抑制多种尼古丁相关线索及尼古丁本身诱导的渴求。
研究设计与样本
- 转化大鼠研究及学术门诊医学中心人体研究,96名男性吸烟者(18-45岁)参与。
- 大鼠非 contingent 注射尼古丁0.15 mg/kg皮下;人体口服普萘洛尔40 mg。
- 69名男性吸烟者完成实验并纳入统计分析:安慰剂+1小时+UCS组24人,普萘洛尔+1小时+UCS组23人,UCS+6小时+普萘洛尔组22人。
主要发现
- 大鼠中尼古丁UCS提取后立即注射普萘洛尔抑制短期戒断后尼古丁CPP(d=1.72,95%CI 0.63-2.77)和操作式寻求(d=1.61,95%CI 0.59-2.60)。
- 大鼠中同样干预抑制长期戒断后尼古丁CPP(d=1.46,95%CI 0.42-2.47)和操作式寻求(d=1.69,95%CI 0.66-2.69)。
- 大鼠中抑制消退后尼古丁启动诱导的CPP复吸(d=1.28,95%CI 0.27-2.26)和操作式寻求复吸(d=1.61,95%CI 0.59-2.60)。
- 吸烟者中口服普萘洛尔降低新学尼古丁CS诱导的偏好(CS1 d=0.61,95%CI 0.02-1.19;CS2 d=0.69,95%CI 0.10-1.28)。
- 吸烟者中降低既有尼古丁CS诱导的偏好(d=0.57,95%CI -0.02至1.15)及尼古丁启动诱导的偏好(CS1 d=0.82,95%CI 0.22-1.41;CS2 d=0.78,95%CI 0.18-1.37;既有CS d=0.92,95%CI 0.31-1.52)。
临床怎么用
- 针对尼古丁相关记忆再巩固窗口给予普萘洛尔可能减少线索诱导的渴求,但需进一步临床试验验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: A relapse into nicotine addiction during abstinence often occurs after the reactivation of nicotine reward memories, either by acute exposure to nicotine (a smoking episode) or by smoking-associated conditioned stimuli (CS). Preclinical studies suggest that drug reward memories can undergo memory reconsolidation after being reactivated, during which they can be weakened or erased by pharmacological or behavioral manipulations. However, translational clinical studies using CS-induced memory retrieval-reconsolidation procedures to decrease drug craving reported inconsistent results. OBJECTIVE: To develop and test an unconditioned stimulus (UCS)-induced retrieval-reconsolidation procedure to decrease nicotine craving among people who smoke. DESIGN, SETTING, AND PARTICIPANTS: A translational rat study and human study in an academic outpatient medical center among 96 male smokers (aged 18- 45 years) to determine the association of propranolol administration within the time window of memory reconsolidation (after retrieval of the nicotine-associated memories by nicotine UCS exposure) with relapse to nicotine-conditioned place preference (CPP) and operant nicotine seeking in rats, and measures of preference to nicotine-associated CS and nicotine craving among people who smoke. INTERVENTION: The study rats were injected noncontingently with the UCS (nicotine 0.15 mg/kg, subcutaneous) in their home cage, and the human study participants administered a dose of propranolol (40 mg, per os; Zhongnuo Pharma). MAIN OUTCOMES AND MEASURES: Nicotine CPP and operant nicotine seeking in rats, and preference and craving ratings for newly learned and preexisting real-life nicotine-associated CS among people who smoke. RESULTS: Sixty-nine male smokers completed the experiment and were included for statistical analysis: 24 in the group that received placebo plus 1 hour plus UCS, 23 who received propranolol plus 1 hour plus UCS, and 22 who received UCS plus 6 hours plus propranolol. In rat relapse models, propranolol injections administered immediately after nicotine UCS-induced memory retrieval inhibited subsequent nicotine CPP and operant nicotine seeking after short (CPP, d = 1.72, 95% CI, 0.63-2.77; operant seeking, d = 1.61, 95% CI, 0.59-2.60) or prolonged abstinence (CPP, d = 1.46, 95% CI, 0.42-2.47; operant seeking: d = 1.69, 95% CI, 0.66-2.69), as well as nicotine priming-induced reinstatement of nicotine CPP (d = 1.28, 95% CI, 0.27-2.26) and operant nicotine seeking (d = 1.61, 95% CI, 0.59-2.60) after extinction. Among the smokers, oral propranolol administered prior to nicotine UCS-induced memory retrieval decreased subsequent nicotine preference induced by newly learned nicotine CS (CS1, Cohen d = 0.61, 95% CI, 0.02-1.19 and CS2, d = 0.69, 95% CI, 0.10-1.28, respectively), preexisting nicotine CS (d = 0.57, 95% CI, -0.02 to 1.15), and nicotine priming (CS1, d = 0.82, 95% CI, 0.22-1.41 and CS2, d = 0.78, 95% CI, 0.18-1.37, respectively; preexisting nicotine CS, d = 0.92, 95% CI, 0.31-1.52), as well as nicotine craving induced by the preexisting nicotine CS (d = 0.64, 95% CI, 0.05-1.22), and nicotine priming (d = 1.15, 95% CI, 0.52-1.76). CONCLUSIONS AND RELEVANCE: In rat-to-human translational study, a novel UCS-induced memory retrieval-reconsolidation interference procedure inhibited nicotine craving induced by exposure to diverse nicotine-associated CS and nicotine itself. This procedure should be studied further in clinical trials.
引用
- Xue YX, Deng JH, Chen YY, et al. Effect of Selective Inhibition of Reactivated Nicotine-Associated Memories With Propranolol on Nicotine Craving. JAMA Psychiatry. 2017. PMID: 28146250. doi:10.1001/jamapsychiatry.2016.3907
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。